Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-022971
Filing Date
2019-11-12
Accepted
2019-11-12 17:09:07
Documents
44
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0919_hoththerapeutics.htm 10-Q 341093
2 AMENDED AND RESTATED EMPLOYMENT AGREEMENT BY AND BETWEEN THE COMPANY AND JANE BE f10q0919ex10-7_hoth.htm EX-10.7 56708
3 CERTIFICATION f10q0919ex31-1_hoth.htm EX-31.1 11950
4 CERTIFICATION f10q0919ex31-2_hoth.htm EX-31.2 14596
5 CERTIFICATION f10q0919ex32-1_hoth.htm EX-32.1 5156
6 CERTIFICATION f10q0919ex32-2_hoth.htm EX-32.2 5497
  Complete submission text file 0001213900-19-022971.txt   2220666

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE hoth-20190930.xml EX-101.INS 293717
8 XBRL SCHEMA FILE hoth-20190930.xsd EX-101.SCH 37388
9 XBRL CALCULATION FILE hoth-20190930_cal.xml EX-101.CAL 31969
10 XBRL DEFINITION FILE hoth-20190930_def.xml EX-101.DEF 128412
11 XBRL LABEL FILE hoth-20190930_lab.xml EX-101.LAB 238844
12 XBRL PRESENTATION FILE hoth-20190930_pre.xml EX-101.PRE 175065
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

EIN.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38803 | Film No.: 191210708
SIC: 2834 Pharmaceutical Preparations